Dysregulation in the Suicide Brain: mRNA Expression of Corticotropin-Releasing Hormone Receptors and GABAA Receptor Subunits in Frontal Cortical Brain Region

Journal of Neuroscience

Volumn 24, Issue 6, 2004, Pages 1478-1485

  Merali, Zul ^a   Du, Lisheng ^a   Hrdina, Pavel ^a   Palkovits, Miklos ^b   Faludi, Gabor ^b   Poulter, Michael O ^c   Anisman, Hymie ^a,c  

^a UNIVERSITY OF OTTAWA   (Canada)

^b SEMMELWEIS UNIVERSITY   (Hungary)

^c CARLETON UNIVERSITY   (Canada)

Author keywords

Cortex; CRF; Depression; GABA; Human suicide; Prefrontal; QPCR

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; 4 AMINOBUTYRIC ACID A RECEPTOR ALPHA1; 4 AMINOBUTYRIC ACID A RECEPTOR ALPHA3; 4 AMINOBUTYRIC ACID A RECEPTOR ALPHA4; CORTICOTROPIN RELEASING FACTOR; CORTICOTROPIN RELEASING FACTOR RECEPTOR 1; CORTICOTROPIN RELEASING FACTOR RECEPTOR 2; MESSENGER RNA; RECEPTOR SUBUNIT; UNCLASSIFIED DRUG;

ARTICLE; BEHAVIOR; CONTROLLED STUDY; CORRELATION ANALYSIS; DEPRESSION; FEMALE; FRONTAL CORTEX; GENE CONTROL; HORMONE ACTION; HUMAN; HUMAN GENOME; HUMAN TISSUE; MALE; POLYMERASE CHAIN REACTION; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; RECEPTOR INTRINSIC ACTIVITY; SUICIDE;

BRAIN; CARRIER PROTEINS; CORTICOTROPIN-RELEASING HORMONE; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; FRONTAL LOBE; HUMANS; MALE; MIDDLE AGED; PROTEIN SUBUNITS; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; RECEPTORS, GABA-A; RNA, MESSENGER; SUICIDE;

EID: 1242314197     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.4734-03.2004     Document Type: Article

References (64)

1. Aguilera G, Rabadan-Diehl C, Nikodemova M (2001) Regulation of pituitary corticotropin-releasing hormone receptors. Peptides 22:769-774.
2. Arango V, Underwood MD, Gubbi AV, Mann JJ (1995) Localized alterations in pre- and postsynaptic serotonin binding sites in the ventrolateral prefrontal cortex of suicide victims. Brain Res 688:1038-1047.
3. Arborelius L, Owens MJ, Plotsky PM, Nemeroff CB (1999) The role of corticotropin-releasing factor in depression and anxiety disorders. J Endocrinol 160:1-12.
4. B) binding sites in postmortem suicide brains. Neuropsychobiology 26:33-36.
5. Austin MC, Janosky JE, Murphy HA (2003) Increased corticotropin-releasing hormone immunoreactivity in monoamine-containing pontine nuclei of depressed suicide men. Mol Psychiatry 8:324-332.
6. Bale TL, Contarino AB, Smith GW, Chan R, Gold LH, Sawchenko PE, Koob GF, Vale WW, Lee KF (2000) Mice deficient for corticotropin-releasing hormone receptor-2 display anxiety-like behaviour and are hypersensitive to stress. Nat Genet 24:410-414.
7. Bissette G, Klimek V, Pan J, Stockmeier C, Ordway G (2003) Elevated concentrations of CRF in the locus coeruleus of depressed subjects. Neuropsychopharmacology 28:1328-1335.
8. Brambilla P, Perez J, Barale F, Schettini G, Soares JC (2003) GABAergic dysfunction in mood disorders. Mol Psychiatry 8:721-737.
9. A receptor subunit expression predicts functional changes in hippocampal dentate granule cells during postnatal development. J Neurochem 77:1266-1278.
10. Buzsaki G (2001) Hippocampal GABAergic interneurons: a physiological perspective. Neurochem Res 26:899-905.
11. A/benzodiazepine binding sites and glutamic acid decarboxylase activity in depressed suicide victims. Brain Res 460:114-123.
12. Chen J, Sochivko D, Beck H, Marechal D, Wiestler OD, Becker AJ (2001) Activity-induced expression of common reference genes in individual CNS neurons. Lab Invest 81:913-916.
13. B binding sites in depressed suicide victims. Psychiatry Res 26:119-129.
14. A receptor subunit expression within hypophysiotropic CRH neurons: a dual hybridization histochemical study. J Comp Neurol 419:344-351.
15. A receptor in the rat stress axis. Brain Res 887:118-124.
16. Dautzenberg FM, Hauger RL (2002) The CRF peptide family and their receptors: yet more partners discovered. Trends Pharmacol Sci 23:71-77.
17. Drevets WC (2000) Neuroimaging studies of mood disorders. Biol Psychiatry 48:813-8129.
18. Drevets WC (2001) Neuroimaging and neuropathological studies of depression: implications for the cognitive-emotional features of mood disorders. Curr Opin Neurobiol 11:240-249.
19. 3H] cAMP binding sites and protein kinase A activity in the prefrontal cortex of suicide victims. Am J Psychiatry 159:66-73.
20. Gilmor ML, Skelton KH, Nemeroff CB, Owens MJ (2003) The effects of chronic treatment with the mood stabilizers valproic acid and lithium on corticotropin-releasing factor neuronal systems. J Pharmacol Exp Ther 305:434-439.
21. Heuser I, Bissette G, Dettling M, Schweiger U, Gotthardt U, Schmider J, Lammers CH, Nemeroff CB, Holsboer F (1998) Cerebrospinal fluid concentrations of corticotropin-releasing hormone, vasopressin, and somatostatin in depressed patients and healthy controls: response to amitriptyline treatment. Depress Anxiety 8:71-79.
22. Holsboer F (2003) Corticotropin-releasing hormone modulators and depression. Curr Opin Investig Drugs 4:46-50.
23. Honig A, Bartlett JR, Bouras N, Bridges PK (1988) Amino acid levels in depression: a preliminary investigation. J Psychiatr Res 22:159-164.
24. Hucks D, Lowther S, Crompton MR, Katona CL, Horton RW (1997) Corticotropin-releasing factor binding sites in cortex of depressed suicides. Psychopharmacology 134:174-178.
25. Kalivas PW, Nakamura M (1999) Neural systems for behavioral activation and reward. Curr Opin Neurobiol 9:223-227.
26. Kling MA, Roy A, Doran AR, Calabrese JR, Rubinow DR, Whitfield Jr HJ, May C, Post RM, Chrousos GP, Gold PW (1991) Cerebrospinal fluid immunoreactive corticotropin-releasing hormone and adrenocorticotropin secretion in Cushing's disease and major depression: potential clinical implications. J Clin Endocrinol Metab 72:260-271.
27. Kling MA, Geracioti TD, Licinio J, Michelson D, Oldfield EH, Gold PW (1994) Effects of electroconvulsive therapy on the CRH-ACTH-cortisol system in melancholic depression: preliminary findings. Psychopharmacol Bull 30:489-494.
28. Korpi ER, Kleinman JE, Wyatt RJ (1988) GABA concentrations in forebrain areas of suicide victims. Biol Psychiatry 23:109-114.
29. Krystal JH, Sanacora G, Blumberg H, Anand A, Charney DS, Marek G, Epperson CN, Goddard A, Mason GF (2002) Glutamate and GABA systems as targets for novel antidepressant and mood-stabilizing treatments. Mol Psychiatry 7:S71-S80.
30. Leake A, Perry EK, Perry RH, Fairbairn AF, Ferrier IN (1990) Cortical concentrations of corticotropin-releasing hormone and its receptor in Alzheimer type dementia and major depression. Biol Psychiatry 28:603-608.
31. Lloyd KG, Zivkovic B, Scatton B, Morselli PL, Bartholini G (1989) The GABAergic hypothesis of depression. Prog Neuropsychopharmacol Biol Psychiatry 13:341-351.
32. Mann JJ, Huang YY, Underwood MD, Kassir SA, Oppenheim S, Kelly TM, Dwork AJ, Arango V (2000) A serotonin transporter gene promoter polymorphism (5-HTTLPR) and prefrontal cortical binding in major depression and suicide. Arch Gen Psychiatry 57:729-738.
33. Merali Z, McIntosh J, Kent P, Michaud D, Anisman H (1998) Aversive and appetitive events evoke the release of corticotropin-releasing hormone land bombesin-like peptides at the central nucleus of the amygdala. J Neurosci 18:4758-4766.
34. Mitchell AJ (1998) The role of corticotropin-releasing factor in depressive illness: a critical review. Neurosci Biobehav Rev 22:635-651.
35. Nemeroff CB (1996) The corticotropin-releasing factor (CRF) hypothesis of depression: new findings and new directions. Mol Psychiatry 1:336-342.
36. Nemeroff CB (2002) New directions in the development of antidepressants: the interface of neurobiology and psychiatry. Hum Psychopharmacol 17 [Suppl 1]:S13-S16.
37. Nemeroff CB, Owens MJ (2003) Treatment of mood disorders. Nat Neurosci 5:1068-1070.
38. Nemeroff CB, Widerlov E, Bissette G, Walleus H, Karlsson I, Eklund K, Kilts CD, Loosen PT, Vale W (1984) Elevated concentrations of CSF corticotropin-releasing factor-like immunoreactivity in depressed patients. Science 226:1342-1344.
39. Nemeroff CB, Owens MJ, Bissette G, Andorn AC, Stanley M (1988) Reduced corticotropin-releasing factor binding sites in the frontal cortex of suicide victims. Arch Gen Psychiatry 45:577-579.
40. Nemeroff CB, Bissette G, Akil H, Fink M (1991) Neuropeptide concentrations in the cerebrospinal fluid of depressed patients treated with electroconvulsive therapy: corticotropin-releasing factor, β-endorphin and somatostatin. Br J Psychiatry 158:59-63.
41. O'Doherty J, Critchley H, Deichmann R, Dolan RJ (2003) Dissociating valence of outcome from behavioral control in human orbital and ventral prefrontal cortices. J Neurosci 23:7931-7939.
42. 2A receptors in the postmortem brains of teenage suicide victims. Am J Psychiatry 159:419-429.
43. Petty F (1995) GABA and mood disorders: a brief review and hypothesis. J Affect Disord 34:275-281.
44. Pozzoli G, Bilezikjian LM, Perrin MH, Blount AL, Vale WW (1996) Corticotropin-releasing factor (CRF) and glucocorticoids modulate the expression of type 1 CRF receptor messenger ribonucleic acid in rat anterior pituitary cell cultures. Endocrinology 137:65-71.
45. Raadsheer FC, Hoogendijk WJ, Stam FC, Tilders FJ, Swaab DF (1994) Increased numbers of corticotropin-releasing hormone expressing neurons in the hypothalamic paraventricular nucleus of depressed patients. Neuroendocrinology 60:436-444.
46. Raadsheer FC, van Heerikhuize JJ, Lucassen PJ, Hoogendijk WJ, Tilders FJ, Swaab DF (1995) Corticotropin-releasing hormone mRNA levels in the paraventricular nucleus of patients with Alzheimer's disease and depression. Am J Psychiatry 152:1372-1376.
47. Rajkowska G (2000) Histopathology of the prefrontal cortex in major depression: what does it tell us about dysfunctional monoaminergic circuits? Prog Brain Res 126:397-412.
48. Reul JMHM, Holsboer F (2002) Corticotropin-releasing factor receptors 1 and 2 in anxiety and depression. Curr Opin Pharamacol 2:23-33.
49. 1 receptor desensitization and downregulation in the human neuroblastoma cell line IMR-32. Brain Res Mol Brain Res 92:115-127.
50. Roy A, Pickar D, Paul S, Doran A, Chrousos GP, Gold PW (1987) CSF corticotropin-releasing hormone in depressed patients and normal control subjects. Am J Psychiatry 144:641-645.
51. Ruggiero DA, Underwood MD, Rice PM, Mann JJ, Arango V (1999) Corticotropic-releasing hormone and serotonin interact in the human brainstem: behavioral implications. Neuroscience 91:1343-1354.
52. SherifF, Marcusson J, Oreland L (1991) Brain γ-aminobutyrate transaminase and monoamine oxidase activities in suicide victims. Eur Arch Psychiatry Clin Neurosci 241:139-144.
53. Shiah IS, Yatham LN (1998) GABA function in mood disorders: an update and critical review. Life Sci 63:1289-1303.
54. Skelton KH, Nemeroff CB, Knight DL, Owens MJ (2000) Chronic administration of the triazolobenzodiazepine alprazolam produces opposite effects on corticotropin-releasing factor and urocortin neuronal systems. J Neurosci 20:1240-1248.
55. Steckler T, Holsboer M (1999) Corticotropin-releasing hormone receptor subtypes and emotion. Biol Psychiatry 46:1480-1508.
56. Stout SC, Owens MJ, Lindsey KP, Knight DL, Nemeroff CB (2001) Effects of sodium valproate on corticotropin-releasing factor systems in rat brain. Neuropsychopharmacology 24:624-631.
57. Sundman I, Allard P, Eriksson A, Marcusson J (1997) GABA uptake sites in frontal cortex from suicide victims and in aging. Neuropsychobiology 35:11-15.
58. Tanji J, Hoshi E (2001) Behavioral planning in the prefrontal cortex. Curr Opin Neurobiol 11:164-170.
59. Tunnicliff G, Malatynska E (2003) Central GABAergic systems and depressive illness. Neurochem Res 28:965-976.
60. Vale W, Vaughan J, Yamamoto G, Bruhn T, Douglas C, Dalton D, Rivier C, Rivier J (1983) Assay of corticotropin-releasing factor. Methods Enzymol 103:565-577.
61. van Heeringen C (2001) Suicide, serotonin, and the brain. Crisis 22:66-70.
62. Wong ML, Kling MA, Munson PJ, Listwak S, Licinio J, Prolo P, Karp B, McCutcheon IE, Geracioti Jr TD, DeBellis MD, Rice KC, Goldstein DS, Veldhuis JD, Chrousos GP, Oldfield EH, McCann SM, Gold PW (2000) Pronounced and sustained central hypernoradrenergic function in major depression with melancholic features: relation to hypercortisolism and corticotropin-releasing hormone. Proc Natl Acad Sci USA 97:325-330.
63. Yan XX, Baram TZ, Gerth A, Schultz L, Ribak CE (1998) Co-localization of corticotropin-releasing hormone with glutamate decarboxylase and calcium-binding proteins in infant rat neocortical interneurons. Exp Brain Res 123:334-340.
64. Zanardi R, Artigas F, Moresco R, Colombo C, Messa C, Gobbo C, Smeraldi E, Fazio F (2001) Increased 5-hydroxytryptamine-2 receptor binding in the frontal cortex of depressed patients responding to paroxetine treatment: a positron emission tomography scan study. J Clin Psychopharmacol 21:53-58.